
Macromo offers a personalized health journey by unifying and simplifying health data through a mobile application, at-home tests, and health consultations. The platform integrates data from wearables, lab tests, and medical records to provide actionable insights and AI-powered personalized protocols for longevity, health, and performance. Key features include blood test importing for insights and trends, health data wallet for storing and tracking, and DNA data analysis. They also offer health coaching and at-home testing for DNA, blood, and gut microbiome. Macromo aims to empower individuals to take control of their health, support healthcare professionals with relevant data, and eventually facilitate diagnoses under medical supervision. They have over 5000 happy customers and a 4.8/5 rating.

Macromo offers a personalized health journey by unifying and simplifying health data through a mobile application, at-home tests, and health consultations. The platform integrates data from wearables, lab tests, and medical records to provide actionable insights and AI-powered personalized protocols for longevity, health, and performance. Key features include blood test importing for insights and trends, health data wallet for storing and tracking, and DNA data analysis. They also offer health coaching and at-home testing for DNA, blood, and gut microbiome. Macromo aims to empower individuals to take control of their health, support healthcare professionals with relevant data, and eventually facilitate diagnoses under medical supervision. They have over 5000 happy customers and a 4.8/5 rating.
Location: Prague, Czech Republic
Founded: 2021
Product: AI-driven mobile health platform combining at-home tests, wearable/medical data aggregation, and health consultations
Users: Trusted by 5,000+ users
Team size: 13 employees
Recent funding: Pre-seed (Sep 7, 2023)
Preventive health, longevity, performance monitoring, and personalized health insights
2021
Healthtech / Preventive Healthcare
880000.00 USD
Pre-seed round recorded on Sep 7, 2023; company announced a strategic investment in Nov 2023 where Martin Radina acquired a 6% stake.
“Includes angel/private investors such as Martin Radina and entities listed as LUMUS Investment Collective and Honza Široký”